This seems to be the week for discussions about potential major breakthroughs in the treatment diseases that have had a devastating impact on millions.It will be wonderful if this works. Fortunately, we'll find out soon since human trials are set to begin shortly.
From NPR's Science Friday...
Researchers reported that large doses of the commonly available vitamin B3 (also known as nicotinamide) were able to reverse the effects of Alzheimer's in mice. But how well does that work apply to people, if at all? In this segment, we'll talk with one of the authors of the new report about the work and about what's currently known about Alzheimer's disease. So far, the work has only been done in mice. If you're interested in participating in a human clinical trial of the research, please call Beatriz Yanez at 949 824 5733.
Listen to the Science Friday segment here:
No comments:
Post a Comment